Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
A legfontosabb adatok
- Ki végzi
- First Affiliated Hospital of Zhejiang University
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 172 fő, tervezett
- Kezdés
- 2021. nov. 3.
- Várható befejezés
- 2027. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Rivaroxaban
- Aspirin
- A regiszteradat frissítve
- 2025. szeptember 25.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a recent deep vein clot (DVT) and a narrowed iliac vein in the pelvis on the same side. They must have had the clot removed with a catheter and a stent placed in the iliac vein.
- Életkor
- 18 years and older
- Nem
- All
- A betegség stádiuma
- Acute DVT that started no more than 3 weeks ago and reaches the thigh or pelvic veins. The iliac vein on the same side is narrowed by more than 50%. The narrowing comes from vein compression (Cockett syndrome) or clot left after removal.
- Korábbi kezelés
- Must have had percutaneous mechanic thrombectomy (PMT), a catheter procedure to remove the clot, with or without catheter directed thrombolysis (CDT). Must have had an iliac vein stent placed within 30 days of PMT or CDT. Cannot join if already taking blood thinners or antiplatelet drugs for other diseases before the DVT.
A részvétel fő kizáró okai
- Long-standing (chronic) DVT, or DVT that started more than 3 weeks ago, or a clot only in the lower leg
- Glomerular filtration rate (kidney function) below 60ml/min
- Varicose veins or poor vein function in the same leg before the DVT
- Heart attack in the past 6 months, or artery blockage, narrowing, aneurysm or tear in the belly or leg arteries
- High bleeding risk, or unable to take antiplatelet drugs or anticoagulants
A regiszter feltételei, szó szerint
Mind a 12 feltétel megnézéseKevesebb
Ki vehet részt
- IC1. Subjects who were diagnosed with deep venous thrombus (DVT) with ipsilateral iliac venous stenosis (>50%). The ipsilateral iliac venous stenosis can be caused either by iliac vein compression (i.e. Cockett syndrome) or residue iliac venous thrombus after percutaneous mechanic thrombectomy
- IC2. Subjects who accepted percutaneous mechanic thrombectomy (PMT) to decrease the burden of thrombus, with or without catheter directed thrombolysis (CDT)
- IC3. Subjects who accepted iliac venous stent(s) implantation during the perioperative period of PMT or CDT (≤30 days post PMT or CDT)
Ki nem vehet részt
- EC3. Subject has glomerular filtration rate < 60ml/min. EC4. Subject has ipsilateral varicose vein or suffers from ipsilateral venous insufficiency prior to the DVT. The manifestations of venous insufficiency include skin pigmentation, edema, lipodermatosclerosis and venous ulcer
- EC9. Subject has been taking anticoagulants or antiplatelet drugs for other diseases prior to the DVT
- EC7. Subject has contraindication to antiplatelet drugs or anticoagulants. EC8. Subject has systemic disease(s) that cannot be treated by current medicine
- Subject who has at least one of the below conditions will be considered at high bleeding risk: Primary history of intracerebral haemorrhage or ischemic stroke, history of other intracranial pathology, recent gastrointestinal bleeding or anaemia due to possible gastrointestinal blood loss, other gastrointestinal pathology associated with increased bleeding risk, liver failure, bleeding diathesis or coagulopathy, extreme old age or frailty, or renal failure requiring dialysis or with eGFR <15ml/min/1.73 m2
- EC10. Subject less than 18 years old or rejected to join this study. EC11. Subject has myocardial infarction during the past 6 months. EC12. EC12. Subject who is at high bleeding risk*
- EC1. Subject has chronic DVT or the onset of DVT is longer than 3 weeks, or chronic DVT
- EC2. Subject has isolated distal DVT, which does not affect ipsilateral femoral or iliac vein
- EC5. Subject has acute arterial embolism on either side or suffers from known moderate or greater stenosis at abdominal aorta, ipsilateral iliac artery and ipsilateral lower extremity artery
- EC6. Subject has known aneurysm(s) or current limiting dissection at abdominal aorta, ipsilateral iliac artery and ipsilateral lower extremity artery
Ez a vizsgálat jelenleg itt érhető el: Kína.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
To evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac vein stenting.
A vizsgálat csoportja
- Anticoagulant plus antiplatelet therapyA vizsgált kezelés
For anticoagulant, it is rivaroxaban 20mg once a day for 6 months. For antiplatelet therapy, it is aspirin 100mg once a day indefinitely.
Kezelés: Rivaroxaban és Aspirin
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- A regiszteradat frissítve
- 2025. szeptember 25.